A probe into the effects of attending a community-based weight management program on weight loss, lipid profile, and blood pressure in long-term cardiac transplant recipients. Cardiac transplantation is an accepted treatment for selected patients with end-stage heart failure. Following transplantation, chronic problems related to maintaining the prevention of the immune response, which is required following cardiac transplantation, effect a significant percentage of transplant recipients. These problems include obesity, high blood pressure, high cholesterol count, kidney problems or failure, diabetes mellitus, and malignancies. Also, at least 50% of the patients have evidence of organ rejection five years after transplantation, a condition which is associated with a mortality rate of more than 40% during the two years after diagnosis. This study will involve approximately 40 people who have had cardiac transplantation. The study is of the influences of two weight management interventions for long-term cardiac transplant recipients. The comparison of effects of a community-based weight management program to a clinic- based weight management education on weight loss, cholesterol levels, blood pressure, overall health, life style, and quality of life will be studied. Involvement in the study will be for six months with 20 minute visits. A questionnaire about life style, weight loss barriers, health management, and quality of life will be completed. Blood pressure, height, weight, and cholesterol levels will be measured. Assignments to each of the types of weight management groups will be randomly decided. Clinic-based subjects will receive an appointment for a consultation visit at the General Clinical Research Center. The community-based subjects will follow the Weight Watchers 1-2-3 Success Program for 26 weeks. Patient charts will be reviewed by a research assistant to obtain information about health and medications taken by the subjects. Patients in the community-based program will have the number of attended meetings examined and food and exercise diaries for choices and exercise.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000065-38
Application #
6419308
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
1977-12-01
Project End
2002-11-30
Budget Start
Budget End
Support Year
38
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Type
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Holkova, Beata; Yazbeck, Victor; Kmieciak, Maciej et al. (2017) A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leuk Lymphoma 58:1349-1357
Corey, Kathleen E; Vuppalanchi, Raj; Vos, Miriam et al. (2015) Improvement in liver histology is associated with reduction in dyslipidemia in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 60:360-7
Eaton, J E; Juran, B D; Atkinson, E J et al. (2015) A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. Aliment Pharmacol Ther 41:980-90
Worthington Jr, Everett L; Berry, Jack W; Hook, Joshua N et al. (2015) Forgiveness-reconciliation and communication-conflict-resolution interventions versus retested controls in early married couples. J Couns Psychol 62:14-27
Holkova, Beata; Kmieciak, Maciej; Perkins, E Brent et al. (2014) Phase I trial of bortezomib (PS-341; NSC 681239) and ""nonhybrid"" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms. Clin Cancer Res 20:5652-62
Lo, D J; Farris, A B; Song, M et al. (2013) Inhibition of ?v?6 promotes acute renal allograft rejection in nonhuman primates. Am J Transplant 13:3085-93
Jones, Robert; Vuky, Jacqueline; Elliott, Tony et al. (2013) Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Invest New Drugs 31:1001-7
Al Hawaj, M A; Martin, E J; Venitz, J et al. (2013) Monitoring rFVIII prophylaxis dosing using global haemostasis assays. Haemophilia 19:409-14
Noureddin, Mazen; Yates, Katherine P; Vaughn, Ivana A et al. (2013) Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients. Hepatology 58:1644-54
Lo, D J; Anderson, D J; Weaver, T A et al. (2013) Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. Am J Transplant 13:320-8

Showing the most recent 10 out of 367 publications